Skip to main content
. 2022 Dec 6;8(2):e002650. doi: 10.1136/rmdopen-2022-002650

Figure 1.

Figure 1

Comparison of neutralising capacity after second COVID-19 vaccination in patients with autoimmune rheumatic diseases (AIRD) and immunocompetent controls (IC). Dotted line marks the cut-off value for positivity following manufacturer’s protocol (≥30%). P values were estimated by a Wald test as combined p value of an unadjusted two-part model.